Search research articles
Contact Us
Filters
Showing results (41-50 of 95) with videos related to
Page
of 10
Sort By:
Drug and Alcohol Dependence
|
July 13, 1999
Oral and intravenous methadone use: some clinical and pharmacokinetic aspects
C Felder, C Uehlinger, P Baumann, et al.
Revue Medicale Suisse
|
October 14, 2008
[Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives]
E Choong, A Solida, C Lechaire, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 1998
Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers
C B Eap, C Schnyder, J Besson, et al.
European Journal of Medical Research
|
January 30, 2008
Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit
Daniele F Zullino, S Krenz, C B Eap, et al.
The Mount Sinai Journal of Medicine, New York
|
November 7, 2000
When "enough" is not enough: new perspectives on optimal methadone maintenance dose
S B Leavitt, M Shinderman, S Maxwell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1994
Increased trimipramine plasma levels during fluvoxamine comedication
E Seifritz, E Holsboer-Trachsler, U Hemmeter, et al.
Pharmacopsychiatry
|
June 16, 2000
Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report
C B Eap, R Bertel-Laubscher, D Zullino, et al.
Addiction Biology
|
May 15, 2003
Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test
J K Melichar, J S Myles, C B Eap, et al.
International Clinical Psychopharmacology
|
May 1, 2002
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
D F Zullino, D Delessert, C B Eap, et al.
Revue Medicale Suisse
|
July 29, 2009
[Genetic aspects of smoking and impact on clinical care]
M Dobrinas, J Cornuz, M Kohler Serra, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 95) with videos related to
Sort By:
Page
of 10
Drug and Alcohol Dependence
|
July 13, 1999
Oral and intravenous methadone use: some clinical and pharmacokinetic aspects
C Felder, C Uehlinger, P Baumann, et al.
Revue Medicale Suisse
|
October 14, 2008
[Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives]
E Choong, A Solida, C Lechaire, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 1998
Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers
C B Eap, C Schnyder, J Besson, et al.
European Journal of Medical Research
|
January 30, 2008
Over- and underreporting of recent drug use in subjects entering an inpatient detoxification unit
Daniele F Zullino, S Krenz, C B Eap, et al.
The Mount Sinai Journal of Medicine, New York
|
November 7, 2000
When "enough" is not enough: new perspectives on optimal methadone maintenance dose
S B Leavitt, M Shinderman, S Maxwell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1994
Increased trimipramine plasma levels during fluvoxamine comedication
E Seifritz, E Holsboer-Trachsler, U Hemmeter, et al.
Pharmacopsychiatry
|
June 16, 2000
Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report
C B Eap, R Bertel-Laubscher, D Zullino, et al.
Addiction Biology
|
May 15, 2003
Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test
J K Melichar, J S Myles, C B Eap, et al.
International Clinical Psychopharmacology
|
May 1, 2002
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
D F Zullino, D Delessert, C B Eap, et al.
Revue Medicale Suisse
|
July 29, 2009
[Genetic aspects of smoking and impact on clinical care]
M Dobrinas, J Cornuz, M Kohler Serra, et al.
Page
of 10